|
MLLT10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.883500E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.295200E-01 |
| Normal-vs-Stage2 |
4.556200E-01 |
| Normal-vs-Stage3 |
4.57840000001042E-06 |
| Normal-vs-Stage4 |
1.263620E-03 |
| Stage1-vs-Stage2 |
9.698000E-01 |
| Stage1-vs-Stage3 |
4.427900E-04 |
| Stage1-vs-Stage4 |
2.332200E-02 |
| Stage2-vs-Stage3 |
1.616280E-02 |
| Stage2-vs-Stage4 |
1.001800E-01 |
| Stage3-vs-Stage4 |
4.433800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.644640E-03 |
| Normal-vs-AfricanAmerican |
2.633600E-01 |
| Normal-vs-Asian |
6.117400E-03 |
| Caucasian-vs-AfricanAmerican |
4.907400E-01 |
| Caucasian-vs-Asian |
7.561500E-03 |
| AfricanAmerican-vs-Asian |
3.448100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.982800E-04 |
| Normal-vs-Female |
3.735400E-01 |
| Male-vs-Female |
6.595400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.234200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.523160E-01 |
| Normal-vs-Age(61-80Yrs) |
1.570670E-04 |
| Normal-vs-Age(81-100Yrs) |
1.798410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.507800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.726600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.377600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.464220E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.396800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.874400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.196020E-02 |
| Normal-vs-Grade 2 |
4.999600E-01 |
| Normal-vs-Grade 3 |
2.204800E-04 |
| Normal-vs-Grade 4 |
2.9976000004428E-07 |
| Grade 1-vs-Grade 2 |
3.316700E-03 |
| Grade 1-vs-Grade 3 |
1.65530999999275E-05 |
| Grade 1-vs-Grade 4 |
1.84839999972652E-07 |
| Grade 2-vs-Grade 3 |
1.504550E-03 |
| Grade 2-vs-Grade 4 |
1.61672999999807E-05 |
| Grade 3-vs-Grade 4 |
2.057800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.671000E-01 |
| Normal-vs-ccB subtype |
4.62539995194078E-09 |
| ccA subtype-vs-ccB subtype |
7.01771973865561E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.385920E-02 |
| Normal-vs-N1 |
4.430400E-02 |
| N0-vs-N1 |
3.441000E-01 |
|
|
